Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma (vol 19, pg 115, 2024)

被引:0
|
作者
France, Nicole L. [1 ]
Blair, Hannah A. [1 ]
机构
[1] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand
关键词
D O I
10.1007/s11523-024-01053-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:481 / 481
页数:1
相关论文
共 50 条
  • [1] Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
    France, Nicole L.
    Blair, Hannah A.
    [J]. TARGETED ONCOLOGY, 2024, 19 (01) : 115 - 123
  • [2] Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
    Nicole L. France
    Hannah A. Blair
    [J]. Targeted Oncology, 2024, 19 : 115 - 123
  • [3] Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma
    de Castria, Tiago Biachi
    Khalil, Danny N.
    Harding, James J.
    O'Reilly, Eileen M.
    Abou-Alfa, Ghassan K.
    [J]. FUTURE ONCOLOGY, 2022, 18 (33) : 3769 - 3782
  • [6] Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma
    Ahmed, Zunirah
    Lee, Sunyoung S.
    Victor III, David W.
    Kodali, Sudha
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1911 - 1922
  • [7] Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
    Duffy, Austin G.
    Ulahannan, Susanna V.
    Makorova-Rusher, Oxana
    Rahma, Osama
    Wedemeyer, Heiner
    Pratt, Drew
    Davis, Jeremy L.
    Hughes, Marybeth S.
    Heller, Theo
    ElGindi, Mei
    Uppala, Ashish
    Korangy, Firouzeh
    Kleiner, David E.
    Figg, William D.
    Venzon, David
    Steinberg, Seth M.
    Venkatesan, Aradhana M.
    Krishnasamy, Venkatesh
    Abi-Jaoudeh, Nadine
    Levy, Elliot
    Wood, Brad J.
    Greten, Tim F.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (03) : 545 - 551
  • [8] The economics of advanced and unresectable hepatocellular carcinoma
    Mattingly, T. Joseph, II
    Shetty, Kirti
    [J]. CANCER, 2022, 128 (22) : 3907 - 3909
  • [9] Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma
    Tamaki, Nobuharu
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Tada, Toshifumi
    Nakamura, Shinichiro
    Ochi, Hironori
    Mashiba, Toshie
    Doisaki, Masao
    Marusawa, Hiroyuki
    Kobashi, Haruhiko
    Fujii, Hideki
    Ogawa, Chikara
    Nonogi, Michiko
    Arai, Hirotaka
    Uchida, Yasushi
    Urawa, Naohito
    Narita, Ryoichi
    Akahane, Takehiro
    Kondo, Masahiko
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Izumi, Namiki
    Kurosaki, Masayuki
    [J]. ANTICANCER RESEARCH, 2024, 44 (09) : 3913 - 3918
  • [10] THERAPY OF UNRESECTABLE HEPATOCELLULAR-CARCINOMA (VOL 332, PG 1294, 1995)
    LEVIN, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (10): : 675 - 675